Cargando…
Ethical challenges and opportunities in the development and approval of novel therapeutics for rare diseases
The development of novel therapeutics for rare “orphan” diseases has brought a growing tension between the desire to accelerate access to these breakthrough therapies and the need to generate quality evidence regarding their safety and efficacy. Accelerating the pace of drug development and approval...
Autores principales: | Djordjevic, Djurdja, McFadyen, Andrew, Anderson, James A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262601/ https://www.ncbi.nlm.nih.gov/pubmed/37323852 http://dx.doi.org/10.1177/27550834231177507 |
Ejemplares similares
-
Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities
por: Stevens, Hannah, et al.
Publicado: (2020) -
Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease
por: Wei, Xiawei, et al.
Publicado: (2019) -
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications
por: McFadyen, James D., et al.
Publicado: (2020) -
Ethics Approval
por: Ross, W M
Publicado: (1994) -
Post-approval process: A challenge for ethics committees
por: Halwai, Aarti, et al.
Publicado: (2023)